GWA
GILD icon

Genesis Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Genesis Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$151K Buy
1,286
+186
+17% +$20.3K 0.12% 82
2015
Q1 		$107K Hold
1,100
– – 0.09% 110
2014
Q4 		$115K Buy
+1,100
New +$114K 0.09% 117

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Genesis Wealth Advisors's GILD Position: Q2 2015 in Review

Genesis Wealth Advisors increased its Gilead Sciences (GILD) stake by 17% in Q2 2015, buying an estimated $20.3K and bringing the position to 1,286 shares worth $151K. The position accounts for 0.12% of the portfolio, ranked #82.

Genesis Wealth Advisors first reported a position in GILD in Q4 2014 and has held it in 3 quarters since. 1,559 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Genesis Wealth Advisors held 1,286 shares of Gilead Sciences worth $151K as of Q2 2015.
  • Genesis Wealth Advisors bought 186 Gilead Sciences shares in Q2 2015, an estimated $20.3K.
  • Gilead Sciences made up 0.12% of Genesis Wealth Advisors's portfolio in Q2 2015, its #82 holding.
  • Genesis Wealth Advisors first reported a position in Gilead Sciences in Q4 2014 and has held it in 3 quarters since.
  • 1,559 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Genesis Wealth Advisors's 13F filing for Q2 2015, filed 24 Aug 2015.